On the contrary, decreasing exosomal PDL1 may reverse the inhibitory state of cancer cells on T cell activity, increasing the number of functional CD8+ T cells and inhibiting the growth of tumors formed by hepatic cancer cells. This evidence concerns the gene CD8A and liver cancer.